FDA Inspection 1122884 — Mylan Laboratories Limited (FDF-2)
The FDA completed an inspection of Mylan Laboratories Limited (FDF-2) on Feb 28, 2020 in Chhatrapati Sambhajinagar. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 28, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chhatrapati Sambhajinagar (India)